About
Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor-binding proteins found in snake venom, these product candidates have the potential to increase survival, improve quality of life and reduce treatment costs for cancer patients.
John Reid
COO00353 86 2644088
johnreid@celticbiotech.com
Website
View WebsiteAddress
25 The Mews
Dublin 1
Ireland
johnreid@celticbiotech.com
Areas of Expertise
- Clinical
- Discovery
- Gene Therapy (non-viral)
- Manufacturing sciences
- Process Development
- Regulatory
- Vaccines